Medicinal Products

Dáil Éireann Debate, Tuesday - 26 May 2026

• Debates
• Find a debate
  • Dáil debates
  • Seanad debates
  • Committee debates
• Find a vote
  • Dáil votes
  • Seanad votes
  • Committee votes
• Parliamentary questions
  • Written questions
  • Oral questions
• Search tips
• Utterances having an adverse effect

Tuesday, 26 May 2026

Questions (1455)

Ken O'Flynn

Question:

1455. Deputy Ken O'Flynn asked the Minister for Health whether Ireland currently operates a distinct reimbursement or pharmacoeconomic assessment pathway for orphan medicines or ultra-rare disease therapies; if so, to provide details of the framework and criteria applied; and if she will make a statement on the matter. [39835/26]

Written answers

Minister for Health

Ireland operates a reimbursement and pharmacoeconomic assessment pathway as outlined in the Health (Pricing and Supply) of Medical Goods Act, 2013. Health (Pricing and Supply of Medical Goods) Act 2013

• Previous Answer
• Next Answer